Published in
Elsevier, The Lancet Oncology, 11(21), p. 1413-1422, 2020
DOI: 10.1016/s1470-2045(20)30453-8
Links
Tools
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
Journal article published in 2020 by
Mariano Provencio 
,
Ernest Nadal,
Amelia Insa ,
María Rosario García-Campelo,
Joaquín Casal-Rubio,
Manuel Dómine,
Margarita Majem,
Delvys Rodríguez-Abreu,
Alex Martínez-Martí,
Javier De Castro Carpeño,
Manuel Cobo,
Guillermo López Vivanco,
Edel Del Barco,
Reyes Bernabé Caro,
Nuria Viñolas
and other authors.
,
Ernest Nadal,
Amelia Insa ,
María Rosario García-Campelo,
Joaquín Casal-Rubio,
Manuel Dómine,
Margarita Majem,
Delvys Rodríguez-Abreu,
Alex Martínez-Martí,
Javier De Castro Carpeño,
Manuel Cobo,
Guillermo López Vivanco,
Edel Del Barco,
Reyes Bernabé Caro,
Nuria Viñolas
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 